Report: FDA lists 106 adverse events for Abbott's rapid COVID-19 test; none for other rapid tests - MassDevice

Abbott’s ID Now test machine (Image from Abbott)

Users of the ABT) ID Now point-of-care diagnostic test for COVID-19 have reported 106 false-negative or otherwise incorrect or inadequate results to the FDA since April — and none for other companies’ rapid diagnostics for the novel coronavirus, according to a report by Kaiser Health News.

That’s up from the 15 adverse event reports the agency reported it had received by May 14, when it issued a warning about the test’s accuracy.  The FDA granted the ID Now test an emergency use ization (EUA) on March 27, and by mid-May said it was investigating whether the false-negative results could be due to the types of swabs used or the type of viral transport media. A preliminary study report by National Public Radio.

Abbott has said that the NYU study results are not consistent with other studies — some with sensitivity performance in the 80th percentile and other studies with sensitivity at or above 90%. One study listed the test’s sensitivity at 94%, the company noted. In a guidance released May 11, the FDA said it considers a 95% accuracy rate for diagnostic tests acceptable.

Abbott began advising customers in mid-April that ID Now is a rapid test that was not designed for use with viral transport media. The company also recommended using dry nasal swabs to collect samples. The 106 reported adverse events took place between April 5 to  April 27, 2020.

An FDA spokesperson told Kaiser Health News that the agency had not received adverse event reports for any other COVID-19 rapid diagnostic test. The news agency also reported that an FDA official said in May that tests conducted outside of a laboratory might still be useful even if they miss one in five positive cases.

President Trump has touted the ID Now as the test used every day in the White House. Kaiser Health News cited contract records that showed the Executive Office of the President has spent roughly $140,000 on Abbott test kits.

The Abbott Park, Ill.-based company said that it has delivered 3.7 million tests to all 50 states with a complaint rate of 0.017% for false negative results, which it has shared with the FDA.

“COVID-19 testing should not be politicized or sensationalized, but rather scientifically assessed as a part of a broad set of countermeasures to protect public health,” Abbott spokesperson Darcy Ross said in an email to MassDevice. “We strive to be as close to perfection as is scientifically possible, and we are reassured by what we’ve seen in the field. We’ve seen accuracy rates in the mid-90s in some studies, including our own, which is incredible when you consider how far we’ve come in only a matter of a few months. This point-of-care device is helping save lives as a part of complex testing regimen that includes additional laboratory testing for patients that require it. Its accessibility and reliability are critical, and we agree with the experts who see the tremendous value it is providing.”





RSS From Medical Design & Outsourcing

  • Why FDA put the pedal to the metal for radar and hummingbirds. And why medtech needs Google.
    In this week’s episode of DeviceTalks Weekly, co-hosts Chris Newmarker and Tom Salemi dig into the recent successes by start-ups Circadia Health and Preceptis Medical, which both saw expedited approval from the FDA due to the pandemic. Circadia Health earned a spot on this year’s “20 medical device startups you need to know” list. Circadia… […]
  • 20 medical device startups you need to know
    The medtech industry isn’t immune from COVID-19 troubles, but exciting innovation continues. These 20 medical device startups have grabbed our attention. Tom Salemi, DeviceTalks Editorial Director and Sean Whooley, Assistant Editor A number of medical device startups continue to make waves across the space, with new technologies and eye-watering fundraising rounds highlighting some exciting prospects.… […]
  • $4.2m project with GE would develop air transport vital-signs patch
    The Nano-Bio Materials Consortium (NBMC) announced this week that it has launched a project with GE Research to develop a medical-grade wireless patch that monitors the vital signs of medical patients during emergency air transport. The device would advance medical care coordination, records management and patient outcomes in aeromedical evacuation and help drive advances in… […]
  • 5 medical device industry supplier innovations you should know
    Innovative medical devices from original equipment manufacturers (OEMs) get a lot of press. But many of those devices wouldn’t exist if it weren’t for innovative contract manufacturers and suppliers. Working with materials as pliable as as polyester and as strong as stainless steel, these companies are always innovating to create new or improved components that… […]
  • Texas governor halts elective procedures in populous counties
    Citing the need to preserve hospital beds for COVID-19 patients, Texas Gov. Greg Abbott today issued an executive order halting elective medical procedures in the state’s four most heavily populated counties . The order, issued this morning, covers the counties of Bexar, Dallas, Harris and Travis counties. Bexar County includes the city of San Antonio. Houston… […]
  • Moderna, Catalent partner on COVID-19 vaccine candidate manufacturing
    Moderna (NSDQ:MRNA) and Catalent (NYSE:CTLT) today announced a collaboration for large-scale, commercial fill-finish manufacturing of Moderna’s mRNA-based COVID-19 vaccine candidate (mRNA-1273) at Catalent’s biologics facility in Bloomington, Ind. Catalent will provide vial filling and packaging capacity, as well as additional staffing required for 24×7 manufacturing operations at the site to support production of an initial 100 million doses… […]
  • Report: New U.S. reshoring agency may loan billions for manufacturing
    The head of the newly formed U.S. International Development Finance Corp. (DFC) said this week that the agency could provide tens of billions of dollars in financing to return manufacturing to the United States, according to a report by Reuters. One of the projects it may finance is a $12 billion semiconductor plant from Taiwan, DFC CEO… […]
  • Webinar: How to protect your medical device manufacturing workers from COVID-19
    Tuesday, July 21, 2020 11:30 a.m. Eastern time / 8:30 a.m. Pacific time     As essential medtech facilities continue operations during COVID-19 and more facilities resume manufacturing, employee safety becomes a very important topic. In this webinar we will explore how to protect your medical device manufacturing workers from COVID-19. The most important step… […]
  • Webinar: How to boost value while reducing the billing cost of your diagnostics
    Thursday, July 30, 2020 2 p.m. Eastern time / 11:30 a.m. Pacific time     Why is it so vital for your organization to understand and maximize its value, even if it’s not in a buying or selling mode? The diagnostics industry — including medical device companies, remote patient monitoring firms, and independent diagnostic testing… […]
  • Biomerics opens online medical balloon store
    Interventional and radiology device contract manufacturer Biomerics announced today that it has launched an online store to sell medical balloons. The new e-commerce platform will sell a range of off-the-shelf nylon, PET, and LDPE medical balloons, enabling engineers to develop and prototype next-generation catheters quickly, according to the Salt Lake City-based company. The online store… […]
  • How to protect connected medical devices from cyberattacks
    Today’s connected-health solutions have dramatically improved patient care. Ensuring that they simultaneously protect patients from hackers requires a closer look at their security, especially as they move to command-and-control models using commercial smartphones. Vinay Gokhale, Thirdwayv No one doubts that connecting medical devices in the Internet of Things (IoT) has delivered many benefits that have… […]

Leave a Reply Cancel reply

You must be logged in to post a comment.